Literature DB >> 18182584

Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutations.

Christian Flotho, Christian P Kratz, Eva Bergsträsser, Henrik Hasle, Jan Starý, Monika Trebo, Marry M van den Heuvel-Eibrink, Dorota Wójcik, Marco Zecca, Franco Locatelli, Charlotte M Niemeyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18182584     DOI： 10.1182/blood-2007-09-111831

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

1.  Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.

Authors:  Elliot Stieglitz; Camille B Troup; Laura C Gelston; John Haliburton; Eric D Chow; Kristie B Yu; Jon Akutagawa; Amaro N Taylor-Weiner; Y Lucy Liu; Yong-Dong Wang; Kyle Beckman; Peter D Emanuel; Benjamin S Braun; Adam Abate; Robert B Gerbing; Todd A Alonzo; Mignon L Loh
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

2.  Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.

Authors:  Rebecca J Chan; Todd Cooper; Christian P Kratz; Brian Weiss; Mignon L Loh
Journal:  Leuk Res       Date:  2008-10-26       Impact factor: 3.156

3.  Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.

Authors:  Michiko Muraoka; Chiho Okuma; Kiichiro Kanamitsu; Hisashi Ishida; Yui Kanazawa; Kana Washio; Masafumi Seki; Motohiro Kato; Junko Takita; Yusuke Sato; Seishi Ogawa; Hirokazu Tsukahara; Megumi Oda; Akira Shimada
Journal:  J Hum Genet       Date:  2016-02-25       Impact factor: 3.172

4.  Phase I combination trial of lenalidomide and azacitidine in patients with higher-risk myelodysplastic syndromes.

Authors:  Mikkael A Sekeres; Alan F List; David Cuthbertson; Ronald Paquette; Rebecca Ganetzky; Rebecca Ganetsky; Deborah Latham; Katarina Paulic; Manuel Afable; Hussain I Saba; Thomas P Loughran; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2010-03-30       Impact factor: 44.544

Review 5.  Whole genome scanning as a cytogenetic tool in hematologic malignancies.

Authors:  Jaroslaw P Maciejewski; Ghulam J Mufti
Journal:  Blood       Date:  2008-05-27       Impact factor: 22.113

6.  RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia.

Authors:  Anna R Poetsch; Daniel B Lipka; Tania Witte; Rainer Claus; Peter Nöllke; Manuela Zucknick; Christiane Olk-Batz; Silvia Fluhr; Michael Dworzak; Barbara De Moerloose; Jan Starý; Marco Zecca; Henrik Hasle; Markus Schmugge; Marry M van den Heuvel-Eibrink; Franco Locatelli; Charlotte M Niemeyer; Christian Flotho; Christoph Plass
Journal:  Epigenetics       Date:  2014-07-31       Impact factor: 4.528

Review 7.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

Review 8.  Pediatric Neoplasms Presenting with Monocytosis.

Authors:  Jacob R Greenmyer; Mira Kohorst
Journal:  Curr Hematol Malig Rep       Date:  2021-02-25       Impact factor: 3.952

Review 9.  Current management of juvenile myelomonocytic leukemia and the impact of RAS mutations.

Authors:  Nao Yoshida; Sayoko Doisaki; Seiji Kojima
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

10.  Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.

Authors:  Nikesh Kotecha; Nikki J Flores; Jonathan M Irish; Erin F Simonds; Debbie S Sakai; Sophie Archambeault; Ernesto Diaz-Flores; Marc Coram; Kevin M Shannon; Garry P Nolan; Mignon L Loh
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.